𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of Parkinson's disease withl-DOPA and an associationl-DOPA plus a DOPA decarboxylase inhibitor

✍ Scribed by C. Fazio; A. Agnoli; M. Casacchia; M. Reitano; S. Ruggieri; C. Barba; F. Volante


Publisher
Springer
Year
1972
Tongue
English
Weight
428 KB
Volume
202
Category
Article
ISSN
0340-5354

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Comparative study of selegiline plus L-d
✍ Timothy Brannan; Dr. Melvin D. Yahr πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 383 KB πŸ‘ 1 views

The long-term effect of selegiline (L-deprenyl) in the treatment of Parkinson's disease has not been clearly delineated. We report on a group of patients whose treatment was initiated with selegiline (n = 43) and then subsequently included L-dopa-carbidopa (Sinemet) and in whom an extended period o